MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma

[1]  M. Kano,et al.  Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2 , 2015, PloS one.

[2]  Naser Asl Aminabadi,et al.  MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. , 2015, Oral oncology.

[3]  A. Kaufmann,et al.  miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines. , 2014, Oncology reports.

[4]  Hongyu Jing,et al.  Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo. , 2014, Oncology reports.

[5]  G. G. Galli,et al.  Prdm5 suppresses ApcMin-driven intestinal adenomas and regulates monoacylglycerol lipase expression , 2014, Oncogene.

[6]  Tong Wu,et al.  miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth , 2014, Molecular Cancer Research.

[7]  Yixiang Wang,et al.  The prognostic value of glycerol‐3‐phosphate dehydrogenase 1‐like expression in head and neck squamous cell carcinoma , 2014, Histopathology.

[8]  Dan Chen,et al.  MicroRNA-99 Family Members Suppress Homeobox A1 Expression in Epithelial Cells , 2013, PloS one.

[9]  Yi Jin,et al.  MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound Healing , 2013, PloS one.

[10]  Yi Jin,et al.  MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas , 2013, Journal of oral & maxillofacial research.

[11]  Xiqiang Liu,et al.  Evaluating the microRNA targeting sites by luciferase reporter gene assay. , 2013, Methods in molecular biology.

[12]  J. Rahnenführer,et al.  Glycerophospholipid profile in oncogene-induced senescence. , 2012, Biochimica et biophysica acta.

[13]  Dongsheng Yu,et al.  Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. , 2012, Oral oncology.

[14]  H. Tai.  Prostaglandin catabolic enzymes as tumor suppressors , 2011, Cancer and Metastasis Reviews.

[15]  Dongsheng Yu,et al.  Molecular Characterization of the MicroRNA-138-Fos-like Antigen 1 (FOSL1) Regulatory Module in Squamous Cell Carcinoma* , 2011, The Journal of Biological Chemistry.

[16]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[17]  J. Chang,et al.  Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. , 2011, Chemistry & biology.

[18]  A. Kolokythas,et al.  Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. , 2011, Oral oncology.

[19]  P. Puigserver,et al.  A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1α Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like , 2011, Molecular and Cellular Biology.

[20]  T. Garland,et al.  Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma , 2011, Human Genetics.

[21]  A. Molinolo,et al.  A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation. , 2010, Oral oncology.

[22]  A. Kolokythas,et al.  MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinoma , 2010, FEBS letters.

[23]  A. Kolokythas,et al.  Downregulation of the Rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma , 2010, International journal of cancer.

[24]  Robert Farber,et al.  Introduction to GPGPUs and Massively Threaded Programming , 2010 .

[25]  Yang Dai,et al.  Computational methods for the identification of microRNA targets. , 2010, Open access bioinformatics.

[26]  C. Wood,et al.  Tumorigenesis and Neoplastic Progression Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression , 2010 .

[27]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[28]  Lu Jiang,et al.  MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. , 2009, Cancer letters.

[29]  O. Monni,et al.  15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer , 2009, Clinical Cancer Research.

[30]  Yandan Yao,et al.  MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.

[31]  Heather R. Roberts,et al.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. , 2009, Carcinogenesis.

[32]  達脇 大.  Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma , 2009 .

[33]  S. Dey,et al.  Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer. , 2008, Cancer research.

[34]  William Ignace Wei,et al.  Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.

[35]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[36]  J. Schwartz,et al.  RNA from brush oral cytology to measure squamous cell carcinoma gene expression. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  Li Mao,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[38]  J. M. Thomson,et al.  MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.

[39]  N. Nikitakis,et al.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma , 2007, Molecular Cancer.

[40]  T. P. Pretlow,et al.  15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis , 2006, Proceedings of the National Academy of Sciences.

[41]  B. Karlan,et al.  15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. , 2006, Cancer research.

[42]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[43]  W. Mann,et al.  Increased PGE2 Levels in Nonmalignant Mucosa Adjacent to Squamous Cell Carcinoma of the Head and Neck , 2005, ORL.

[44]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[45]  H. Tai,et al.  15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer* , 2005, Journal of Biological Chemistry.

[46]  Bhuvanesh Singh,et al.  Genetic abnormalities associated with nodal metastasis in head and neck cancer , 2004, Head & neck.

[47]  K. Subbaramaiah,et al.  Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. , 2003, Cancer cell.

[48]  R. DuBois,et al.  Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor Receptor* , 2003, Journal of Biological Chemistry.

[49]  Jean Wu,et al.  Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. , 2003, Oral oncology.

[50]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[51]  A. Look,et al.  E2A-HLF usurps control of evolutionarily conserved survival pathways , 2001, Oncogene.

[52]  T. Matsumura,et al.  Establishment of High and Low Metastasis Cell Lines Derived from a Human Tongue Squamous Cell Carcinoma , 1998, Invasion and Metastasis.

[53]  J. Manni.  Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. , 1997, Head & neck.

[54]  C. Snyderman,et al.  Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients , 1995, Head & neck.

[55]  R. Spiro,et al.  Improved survival in the treatment of squamous carcinoma of the oral tongue. , 1993, American journal of surgery.

[56]  M. Cleary,et al.  Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. , 1992, Genes & development.

[57]  S. Raimondi,et al.  Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. , 1992, Science.

[58]  A. Borges,et al.  Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. , 1989, American journal of surgery.

[59]  F. Demard,et al.  Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. , 1988, European journal of cancer & clinical oncology.

[60]  T. Carey,et al.  Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. , 1981, Archives of otolaryngology.

[61]  J. Rheinwald,et al.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. , 1981, Cancer research.